JAZZ Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $9,992,963.00

Insider Selling (Last 12 Months): $26,826,354.27

Jazz Pharmaceuticals Insider Trading History Chart

Jazz Pharmaceuticals Share Price & Price History

^$166.91

▼ -0.19 (-0.11%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Jazz Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/26/2025	Bruce C. Cozadd	Director	Sell	77,500	$177.81	$13,780,275.00	393,332
11/20/2025	Heather Ann Mcsharry	Director	Sell	3,415	$177.78	$607,118.70	20,449
11/18/2025	Bruce C. Cozadd	Director	Sell	18,000	$181.09	$3,259,620.00	390,826
11/18/2025	Patricia Carr	CAO	Sell	5,319	$182.06	$968,377.14	7,012
11/18/2025	Rick E. Winningham	Director	Sell	5,500	$180.86	$994,730.00	8,893
11/17/2025	Robert Iannone	EVP	Sell	7,159	$168.26	$1,204,573.34	72,628
10/3/2025	Bruce C. Cozadd	Director	Sell	3,500	$140.00	$490,000.00	408,826
10/1/2025	Bruce C. Cozadd	Director	Sell	2,000	$131.78	$263,560.00	412,326
9/2/2025	Bruce C. Cozadd	Director	Sell	6,000	$128.62	$771,720.00	429,973
7/1/2025	Bruce C. Cozadd	CEO	Sell	1,000	$107.63	$107,630.00	436,973
6/2/2025	Bruce C. Cozadd	CEO	Sell	500	$107.90	$53,950.00	438,473
5/12/2025	Seamus Mulligan	Director	Buy	1,621	$103.00	$166,963.00	101,621
5/9/2025	Seamus Mulligan	Director	Buy	100,000	$98.26	$9,826,000.00	100,000
5/1/2025	Bruce C. Cozadd	CEO	Sell	1,000	$116.35	$116,350.00	439,307
4/1/2025	Bruce C. Cozadd	CEO	Sell	1,500	$123.75	$185,625.00	440,307
3/10/2025	Patricia Carr	CAO	Sell	1,140	$137.81	$157,103.40	7,012
3/10/2025	Robert Iannone	CMO	Sell	2,403	$138.41	$332,599.23	79,621
3/7/2025	Robert Iannone	CMO	Sell	7,080	$138.60	$981,288.00	82,024
3/3/2025	Bruce C. Cozadd	CEO	Sell	6,500	$144.25	$937,625.00	464,058
2/27/2025	Neena M. Patil	EVP	Sell	3,800	$144.87	$550,506.00	33,318
2/27/2025	Patricia Carr	CAO	Sell	4,813	$144.42	$695,093.46	8,237
2/3/2025	Bruce C. Cozadd	CEO	Sell	1,500	$122.31	$183,465.00	439,744
1/2/2025	Bruce C. Cozadd	CEO	Sell	1,500	$123.43	$185,145.00	425,525
12/2/2024	Bruce C. Cozadd	CEO	Sell	2,000	$121.17	$242,340.00	427,025
12/2/2024	Patricia Carr	CAO	Sell	53	$122.49	$6,491.97	6,596
11/8/2024	Neena M. Patil	EVP	Sell	3,700	$123.41	$456,617.00	33,048
11/1/2024	Bruce C. Cozadd	CEO	Sell	1,000	$110.84	$110,840.00	428,976
9/6/2024	Mary Elizabeth Henderson	SVP	Sell	1,410	$108.30	$152,703.00	14,531
6/7/2024	Patricia Carr	CAO	Sell	163	$108.83	$17,739.29	6,596
5/3/2024	Neena M. Patil	EVP	Sell	5,000	$109.65	$548,250.00	36,629
3/6/2024	Patricia Carr	CAO	Sell	1,936	$119.64	$231,623.04	8,364
3/1/2024	Philip L. Johnson	CFO	Buy	12,000	$119.65	$1,435,800.00	27,932
12/4/2023	Mark Douglas Smith	Director	Sell	417	$119.27	$49,735.59	6,888
9/1/2023	Neena M. Patil	EVP	Sell	1,500	$144.25	$216,375.00	29,186
8/29/2023	Patricia Carr	CAO	Sell	142	$143.47	$20,372.74	5,986
8/15/2023	Neena M. Patil	EVP	Sell	750	$139.59	$104,692.50	30,686
8/14/2023	Patricia Carr	CAO	Sell	158	$138.16	$21,829.28	6,128
8/14/2023	Rick E. Winningham	Director	Sell	1,241	$138.16	$171,456.56	10,444
6/7/2023	Patricia Carr	CAO	Sell	126	$127.92	$16,117.92	6,286
6/1/2023	Neena M. Patil	EVP	Sell	1,600	$127.98	$204,768.00	32,826
5/18/2023	Renée D. Galá	CFO	Sell	6,000	$131.75	$790,500.00	35,978
3/15/2023	Patricia Carr	CAO	Sell	1,023	$133.22	$136,284.06	6,286
3/8/2023	Kim Sablich	EVP	Sell	3,013	$139.74	$421,036.62	30,560
3/7/2023	Kenneth W. O'Keefe	Director	Sell	2,690	$138.39	$372,269.10	22,889
3/6/2023	Finbar Larkin	SVP	Sell	1,706	$143.92	$245,527.52	23,854
3/5/2023	Patricia Carr	CAO	Sell	1,148	$140.76	$161,592.48	7,309
2/1/2023	Bruce C. Cozadd	CEO	Sell	1,000	$155.79	$155,790.00	367,078
1/3/2023	Bruce C. Cozadd	CEO	Sell	3,000	$159.86	$479,580.00	368,078
1/3/2023	Samantha Pearce	SVP	Sell	531	$159.59	$84,742.29	11,309
12/21/2022	Renée D. Galá	CFO	Sell	2,635	$160.00	$421,600.00	32,558
12/13/2022	Samantha Pearce	SVP	Sell	531	$155.45	$82,543.95	11,309
12/9/2022	Robert Iannone	EVP	Sell	1,844	$151.54	$279,439.76	36,316
12/5/2022	Patricia Carr	CAO	Sell	63	$152.06	$9,579.78	5,934
12/2/2022	Jennifer E. Cook	Director	Sell	420	$154.68	$64,965.60	5,471
12/1/2022	Bruce C. Cozadd	CEO	Sell	1,000	$157.00	$157,000.00	371,078

SEC Filings (Institutional Ownership Changes) for Jazz Pharmaceuticals (NASDAQ:JAZZ)

89.14% of Jazz Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Jazz Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	Swiss Life Asset Management Ltd	2,692	$0.36M	0.0%	N/A	0.004%
12/2/2025	Goldentree Asset Management LP	1,137,106	$149.60M	12.4%	N/A	1.871%
12/1/2025	Groupama Asset Managment	2,576	$0.34M	0.0%	-70.5%	0.004%
12/1/2025	Cambria Investment Management L.P.	5,889	$0.78M	0.0%	+7.1%	0.010%
11/21/2025	CIBC Bancorp USA Inc.	2,068	$0.27M	0.0%	N/A	0.003%
11/19/2025	Faithward Advisors LLC	27,904	$3.68M	0.5%	+93.4%	0.046%
11/19/2025	Sunbelt Securities Inc.	400	$53K	0.0%	N/A	0.001%
11/19/2025	Coldstream Capital Management Inc.	4,472	$0.59M	0.0%	+36.5%	0.007%
11/19/2025	Danske Bank A S	300	$40K	0.0%	N/A	0.000%
11/19/2025	Caitong International Asset Management Co. Ltd	356	$47K	0.0%	+1,383.3%	0.001%
11/17/2025	NewEdge Advisors LLC	900	$0.12M	0.0%	-6.9%	0.001%
11/17/2025	Krensavage Asset Management LLC	167,816	$22.12M	9.4%	+1.8%	0.276%
11/17/2025	CANADA LIFE ASSURANCE Co	35,106	$4.53M	0.0%	+0.5%	0.058%
11/17/2025	Woodline Partners LP	264,968	$34.92M	0.2%	+710.7%	0.436%
11/17/2025	Dark Forest Capital Management LP	11,540	$1.52M	0.0%	-54.7%	0.019%
11/17/2025	Alyeska Investment Group L.P.	205,954	$27.15M	0.1%	+1.0%	0.339%
11/17/2025	Utah Retirement Systems	3,100	$0.41M	0.0%	-68.4%	0.005%
11/17/2025	Verition Fund Management LLC	27,299	$3.60M	0.0%	-16.5%	0.045%
11/17/2025	Vestal Point Capital LP	500,000	$65.90M	3.0%	-58.3%	0.823%
11/17/2025	Quantessence Capital LLC	1,609	$0.21M	0.1%	N/A	0.003%
11/17/2025	Quarry LP	2,125	$0.28M	0.1%	-41.0%	0.003%
11/17/2025	Qube Research & Technologies Ltd	56,244	$7.41M	0.0%	-54.4%	0.093%
11/17/2025	Public Employees Retirement System of Ohio	19,144	$2.52M	0.0%	-3.1%	0.032%
11/17/2025	Nomura Holdings Inc.	14,376	$1.90M	0.0%	-21.7%	0.024%
11/17/2025	Northwestern Mutual Wealth Management Co.	3,331	$0.44M	0.0%	+20.0%	0.005%
11/17/2025	Northern Trust Corp	503,550	$66.37M	0.0%	0.0%	0.829%
11/17/2025	Mariner LLC	20,275	$2.67M	0.0%	+8.5%	0.033%
11/17/2025	Measured Wealth Private Client Group LLC	4,648	$0.61M	0.2%	-4.3%	0.008%
11/17/2025	Mercer Global Advisors Inc. ADV	2,480	$0.33M	0.0%	-18.5%	0.004%
11/17/2025	National Bank of Canada FI	715	$94K	0.0%	+66.7%	0.001%
11/17/2025	Millennium Management LLC	269,107	$35.47M	0.0%	-60.8%	0.443%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	31,689	$4.18M	0.0%	-38.0%	0.052%
11/17/2025	Iron Triangle Partners LP	150,000	$19.77M	2.8%	N/A	0.247%
11/17/2025	Holocene Advisors LP	605,109	$79.75M	0.2%	+28.8%	0.996%
11/17/2025	Gotham Asset Management LLC	51,192	$6.75M	0.0%	-25.2%	0.084%
11/17/2025	Fred Alger Management LLC	2,193	$0.29M	0.0%	-2.8%	0.004%
11/17/2025	Focus Partners Wealth	4,543	$0.60M	0.0%	-15.2%	0.007%
11/17/2025	Distillate Capital Partners LLC	111,383	$14.68M	0.8%	+3.3%	0.183%
11/17/2025	CSM Advisors LLC	6,046	$0.80M	0.0%	+18.6%	0.010%
11/17/2025	California Public Employees Retirement System	194,807	$25.68M	0.0%	-14.7%	0.321%
11/17/2025	Bank of America Corp DE	967,901	$127.57M	0.0%	-8.0%	1.593%
11/17/2025	Aristotle Capital Management LLC	158,056	$20.83M	0.0%	-4.5%	0.260%
11/17/2025	Alliancebernstein L.P.	127,248	$16.77M	0.0%	-11.8%	0.209%
11/17/2025	Ameriprise Financial Inc.	1,847,455	$243.50M	0.1%	-1.1%	3.040%
11/14/2025	Creative Planning	3,666	$0.48M	0.0%	+36.4%	0.006%
11/14/2025	Schonfeld Strategic Advisors LLC	436,443	$57.52M	0.3%	+592.1%	0.718%
11/14/2025	Lazard Asset Management LLC	13,642	$1.80M	0.0%	-100.0%	0.022%
11/14/2025	AQR Capital Management LLC	698,941	$90.96M	0.1%	-12.1%	1.150%
11/14/2025	SummitTX Capital L.P.	23,005	$3.03M	0.1%	-28.4%	0.038%
11/14/2025	AQR Arbitrage LLC	33,322	$4.34M	0.1%	-58.9%	0.055%
11/14/2025	Raymond James Financial Inc.	158,866	$20.94M	0.0%	-0.1%	0.261%
11/14/2025	Man Group plc	43,166	$5.69M	0.0%	+199.4%	0.071%
11/14/2025	Hotchkis & Wiley Capital Management LLC	138,109	$18.20M	0.1%	+364.1%	0.227%
11/14/2025	Occudo Quantitative Strategies LP	4,892	$0.65M	0.1%	-18.8%	0.008%
11/14/2025	California State Teachers Retirement System	55,214	$7.28M	0.0%	+1.5%	0.091%
11/14/2025	Logan Capital Management Inc.	2,568	$0.34M	0.0%	+134.7%	0.004%
11/14/2025	ADAR1 Capital Management LLC	2,500	$0.33M	0.0%	-9.1%	0.004%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	31,570	$4.16M	0.0%	-59.5%	0.052%
11/14/2025	Acuta Capital Partners LLC	25,114	$3.31M	3.4%	-4.4%	0.041%
11/14/2025	Balyasny Asset Management L.P.	433,139	$57.09M	0.1%	+29.2%	0.713%
11/14/2025	Fiduciary Trust Co	12,414	$1.64M	0.0%	-8.1%	0.020%
11/14/2025	Shay Capital LLC	15,000	$1.98M	0.2%	N/A	0.025%
11/14/2025	Brooklyn Investment Group	1,950	$0.26M	0.0%	+144.7%	0.003%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	169,687	$22.37M	0.0%	-38.1%	0.279%
11/14/2025	Two Sigma Investments LP	4,173	$0.55M	0.0%	-90.7%	0.007%
11/14/2025	Vident Advisory LLC	24,975	$3.29M	0.0%	-25.7%	0.041%
11/14/2025	Squarepoint Ops LLC	15,817	$2.09M	0.0%	N/A	0.026%
11/14/2025	Towarzystwo Funduszy Inwestycyjnych PZU SA	1,115	$0.15M	0.0%	-49.8%	0.002%
11/14/2025	Wellington Management Group LLP	129,199	$17.03M	0.0%	+8.2%	0.213%
11/14/2025	Glenmede Investment Management LP	7,826	$1.03M	0.0%	-74.1%	0.013%
11/13/2025	Pathstone Holdings LLC	10,455	$1.38M	0.0%	+14.3%	0.017%
11/13/2025	Boston Partners	15,910	$2.10M	0.0%	+42.7%	0.026%
11/13/2025	Platinum Investment Management Ltd.	2,197	$0.29M	0.0%	-6.7%	0.004%
11/13/2025	Kennedy Capital Management LLC	17,423	$2.30M	0.1%	+68.1%	0.029%
11/13/2025	Invesco Ltd.	171,206	$22.57M	0.0%	-40.0%	0.282%
11/13/2025	Sei Investments Co.	100,256	$13.22M	0.0%	+19.4%	0.165%
11/13/2025	Connor Clark & Lunn Investment Management Ltd.	93,173	$12.28M	0.0%	-33.9%	0.153%
11/13/2025	Kendall Capital Management	8,454	$1.11M	0.3%	+2.7%	0.014%
11/13/2025	Mackenzie Financial Corp	207,666	$27.37M	0.0%	-0.4%	0.342%
11/13/2025	Franklin Resources Inc.	688,916	$90.80M	0.0%	-2.5%	1.134%
11/13/2025	Van ECK Associates Corp	24,295	$3.20M	0.0%	-25.9%	0.040%
11/13/2025	Capital World Investors	2,554,867	$336.73M	0.0%	+0.4%	4.205%
11/13/2025	Bank of Montreal Can	337,162	$44.44M	0.0%	+2.6%	0.555%
11/13/2025	Legal & General Group Plc	119,877	$15.80M	0.0%	-35.5%	0.197%
11/13/2025	Vestcor Inc	9,194	$1.21M	0.0%	-22.1%	0.015%
11/13/2025	Swiss National Bank	111,400	$14.68M	0.0%	+1.1%	0.183%
11/13/2025	Private Advisor Group LLC	2,747	$0.36M	0.0%	-15.3%	0.005%
11/13/2025	Pinnacle Associates Ltd.	11,120	$1.47M	0.0%	+2.9%	0.018%
11/13/2025	Natixis Advisors LLC	26,549	$3.50M	0.0%	+25.2%	0.044%
11/13/2025	Rhenman & Partners Asset Management AB	95,030	$12.53M	1.4%	-12.8%	0.156%
11/13/2025	Blair William & Co. IL	2,107	$0.28M	0.0%	+5.0%	0.003%
11/13/2025	First Trust Advisors LP	241,870	$31.88M	0.0%	+17.6%	0.398%
11/13/2025	Neo Ivy Capital Management	13,930	$1.84M	0.4%	N/A	0.023%
11/12/2025	Crossmark Global Holdings Inc.	3,674	$0.48M	0.0%	-74.0%	0.006%
11/12/2025	Orion Porfolio Solutions LLC	30,242	$3.99M	0.0%	+2.0%	0.050%
11/12/2025	GW&K Investment Management LLC	454,712	$59.93M	0.5%	-3.8%	0.748%
11/12/2025	Dimensional Fund Advisors LP	2,836,652	$373.86M	0.1%	+11.8%	4.668%
11/12/2025	Cresset Asset Management LLC	13,978	$1.84M	0.0%	-5.6%	0.023%
11/12/2025	Victory Capital Management Inc.	305,341	$40.24M	0.0%	-14.5%	0.502%
11/12/2025	CI Investments Inc.	787	$0.10M	0.0%	-28.1%	0.001%

Data available starting January 2016

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia; Xyrem to treat cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut and Dravet syndromes, or tuberous sclerosis complex; Zepzelca to treat metastatic small cell lung cancer, or with disease progression on or after platinum-based chemotherapy; Rylaze for acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Defitelio to treat severe hepatic veno-occlusive disease; and Vyxeos for newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Zepzelca for the treatment of patients with select relapsed/refractory solid tumors based on limited response in three solid tumor cohorts; JZP815, a pan-RAF kinase inhibitor that targets components of the mitogen-activated protein kinase; JZP898, a conditionally-activated interferon alpha molecule; Epidiolex to treat LGS, DS, and TSC; Suvecaltamide to treat parkinson's disease tremor; JZP150, a fatty acid amide hydrolase inhibitor program to treat post-traumatic stress disorder; and JZP441 to treat narcolepsy, IH, and other sleep disorders. The company has licensing and collaboration agreements with XL-protein GmbH to extend the plasma half-life of selected asparaginase product candidates; Redx Pharma plc for preclinical activities Ras/Raf/MAP kinase pathway program; and Autifony Therapeutics Limited on discovering and developing drug candidates targeting two different ion channel targets associated with neurological disorders. The company was incorporated in 2003 and is headquartered in Dublin, Ireland.

Today's Range

Now: $166.91

$164.44

$167.30

50 Day Range

MA: $146.99

$127.00

$180.90

52 Week Range

Now: $166.91

$95.49

$182.99

Volume

844,967 shs

Average Volume

1,579,805 shs

Market Capitalization

$10.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top insider shareholders include:
Bruce C Cozadd (CEO)
Bruce C Cozadd (Director)
Seamus Mulligan (Director)
Robert Iannone (CMO)
Robert Iannone (EVP)
Neena M Patil (EVP)
Philip L Johnson (CFO)
Heather Ann Mcsharry (Director)
Mary Elizabeth Henderson (SVP)
Rick E Winningham (Director)
Patricia Carr (CAO)
Mark Douglas Smith (Director)
Learn More about top insider investors at Jazz Pharmaceuticals.
Who are the major institutional investors of Jazz Pharmaceuticals?: Jazz Pharmaceuticals' top institutional investors include:
Vanguard Group Inc. — 9.74%
Dimensional Fund Advisors LP — 4.67%
Capital World Investors — 4.20%
LSV Asset Management — 4.14%
JPMorgan Chase & Co. — 3.07%
Ameriprise Financial Inc. — 3.04%
Learn More about top institutional investors of Jazz Pharmaceuticals stock.
Which major investors are selling Jazz Pharmaceuticals stock?: Within the previous quarter, JAZZ stock was sold by these institutional investors:
Lazard Asset Management LLC
Vestal Point Capital LP
Millennium Management LLC
Perpetual Ltd
Pacer Advisors Inc.
Vanguard Group Inc.
Polaris Capital Management LLC
Invesco Ltd.
In the previous year, company insiders that have sold Jazz Pharmaceuticals company stock include:
Bruce C Cozadd (CEO)
Bruce C Cozadd (Director)
Seamus Mulligan (Director)
Robert Iannone (CMO)
Robert Iannone (EVP)
Neena M Patil (EVP)
Philip L Johnson (CFO)
Heather Ann Mcsharry (Director)
Learn More investors selling Jazz Pharmaceuticals stock.
Which major investors are buying Jazz Pharmaceuticals stock?: During the last quarter, JAZZ stock was acquired by institutional investors including:
Goldentree Asset Management LP
Schonfeld Strategic Advisors LLC
Dimensional Fund Advisors LP
Woodline Partners LP
Wedge Capital Management L L P NC
Iron Triangle Partners LP
JPMorgan Chase & Co.
Holocene Advisors LP
During the last year, these company insiders have bought Jazz Pharmaceuticals stock:
Bruce C Cozadd (CEO)
Bruce C Cozadd (Director)
Learn More investors buying Jazz Pharmaceuticals stock.